Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Prepaid Assets (2020 - 2025)

Xeris Biopharma Holdings' Prepaid Assets history spans 6 years, with the latest figure at $9.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 28.14% year-over-year to $9.5 million, compared with a TTM value of $9.5 million through Dec 2025, up 28.14%, and an annual FY2025 reading of $9.5 million, up 28.14% over the prior year.
  • Prepaid Assets for Q4 2025 was $9.5 million at Xeris Biopharma Holdings, down from $11.2 million in the prior quarter.
  • The five-year high for Prepaid Assets was $11.2 million in Q3 2025, with the low at $3.6 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $7.3 million, with a median of $7.4 million recorded in 2024.
  • Year-over-year, Prepaid Assets soared 119.07% in 2022 and then plummeted 37.78% in 2023.
  • Tracing XERS's Prepaid Assets over 5 years: stood at $4.6 million in 2021, then surged by 102.38% to $9.3 million in 2022, then crashed by 37.78% to $5.8 million in 2023, then grew by 28.95% to $7.5 million in 2024, then grew by 28.14% to $9.5 million in 2025.
  • Per Business Quant, the three most recent readings for XERS's Prepaid Assets are $9.5 million (Q4 2025), $11.2 million (Q3 2025), and $6.0 million (Q2 2025).